NPS Pharmaceutical conducted a two-year phase III STEPS 2 extension study and would like to include the new data on the Gattex label. The FDA’s decision on label expansion should come by June 2014.
The pharmaceutical company presented this data at the most recent American College of Gastroenterology annual meeting.
Gattex has been available in the U.S. since February and was cleared in the European Union in 2012.
More Articles on Gastroenterology:
5 Key Trends in GI/Endoscopy
The Latest in GI Cancer: Q&A With Dr. Neville Bamji of New York Gastroenterology Associates
St. Anthony Healthplex, Endoscopy Department Construction Underway
